Logo image of SCANA.OL

SCANA ASA (SCANA.OL) Stock Fundamental Analysis

OSL:SCANA - Euronext Oslo - NO0003053308 - Common Stock - Currency: NOK

1.528  +0 (+0.13%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SCANA. SCANA was compared to 107 industry peers in the Machinery industry. While SCANA is still in line with the averages on profitability rating, there are concerns on its financial health. An interesting combination arises when we look at growth and value: SCANA is growing strongly while it also seems undervalued.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year SCANA was profitable.
In the past year SCANA had a positive cash flow from operations.
Of the past 5 years SCANA 4 years were profitable.
SCANA had a positive operating cash flow in each of the past 5 years.
SCANA.OL Yearly Net Income VS EBIT VS OCF VS FCFSCANA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

SCANA has a worse Return On Assets (0.65%) than 65.42% of its industry peers.
The Return On Equity of SCANA (1.56%) is worse than 65.42% of its industry peers.
SCANA's Return On Invested Capital of 3.15% is on the low side compared to the rest of the industry. SCANA is outperformed by 66.36% of its industry peers.
Industry RankSector Rank
ROA 0.65%
ROE 1.56%
ROIC 3.15%
ROA(3y)2.29%
ROA(5y)7.89%
ROE(3y)5.28%
ROE(5y)21.93%
ROIC(3y)N/A
ROIC(5y)N/A
SCANA.OL Yearly ROA, ROE, ROICSCANA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

The Profit Margin of SCANA (0.55%) is worse than 68.22% of its industry peers.
In the last couple of years the Profit Margin of SCANA has grown nicely.
SCANA has a worse Operating Margin (2.36%) than 73.83% of its industry peers.
In the last couple of years the Operating Margin of SCANA has grown nicely.
SCANA has a better Gross Margin (54.88%) than 73.83% of its industry peers.
SCANA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.36%
PM (TTM) 0.55%
GM 54.88%
OM growth 3Y22.03%
OM growth 5Y228.51%
PM growth 3Y-21.04%
PM growth 5Y11%
GM growth 3Y5.71%
GM growth 5Y6.61%
SCANA.OL Yearly Profit, Operating, Gross MarginsSCANA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SCANA is destroying value.
SCANA has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SCANA has more shares outstanding
The debt/assets ratio for SCANA has been reduced compared to a year ago.
SCANA.OL Yearly Shares OutstandingSCANA.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
SCANA.OL Yearly Total Debt VS Total AssetsSCANA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

SCANA has a debt to FCF ratio of 7.98. This is a slightly negative value and a sign of low solvency as SCANA would need 7.98 years to pay back of all of its debts.
SCANA has a Debt to FCF ratio of 7.98. This is comparable to the rest of the industry: SCANA outperforms 42.06% of its industry peers.
SCANA has a Debt/Equity ratio of 0.60. This is a neutral value indicating SCANA is somewhat dependend on debt financing.
SCANA has a Debt to Equity ratio of 0.60. This is in the lower half of the industry: SCANA underperforms 64.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 7.98
Altman-Z N/A
ROIC/WACC0.39
WACC8.08%
SCANA.OL Yearly LT Debt VS Equity VS FCFSCANA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

SCANA has a Current Ratio of 1.03. This is a normal value and indicates that SCANA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.03, SCANA is doing worse than 83.18% of the companies in the same industry.
SCANA has a Quick Ratio of 1.03. This is a bad value and indicates that SCANA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.78, SCANA is doing worse than 69.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.78
SCANA.OL Yearly Current Assets VS Current LiabilitesSCANA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

7

3. Growth

3.1 Past

SCANA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -93.11%.
Measured over the past years, SCANA shows a very strong growth in Earnings Per Share. The EPS has been growing by 21.20% on average per year.
The Revenue has been growing slightly by 2.94% in the past year.
SCANA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 39.74% yearly.
EPS 1Y (TTM)-93.11%
EPS 3Y-9.23%
EPS 5Y21.2%
EPS Q2Q%-162.54%
Revenue 1Y (TTM)2.94%
Revenue growth 3Y84.93%
Revenue growth 5Y39.74%
Sales Q2Q%-31.93%

3.2 Future

The Earnings Per Share is expected to grow by 34.80% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 10.21% on average over the next years. This is quite good.
EPS Next Y19.33%
EPS Next 2Y39.53%
EPS Next 3Y34.8%
EPS Next 5YN/A
Revenue Next Year1.92%
Revenue Next 2Y9.54%
Revenue Next 3Y10.21%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SCANA.OL Yearly Revenue VS EstimatesSCANA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
SCANA.OL Yearly EPS VS EstimatesSCANA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 9.55, the valuation of SCANA can be described as reasonable.
85.05% of the companies in the same industry are more expensive than SCANA, based on the Price/Earnings ratio.
SCANA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.46.
A Price/Forward Earnings ratio of 4.79 indicates a rather cheap valuation of SCANA.
Based on the Price/Forward Earnings ratio, SCANA is valued cheaper than 97.20% of the companies in the same industry.
SCANA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.44.
Industry RankSector Rank
PE 9.55
Fwd PE 4.79
SCANA.OL Price Earnings VS Forward Price EarningsSCANA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SCANA indicates a somewhat cheap valuation: SCANA is cheaper than 63.55% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SCANA indicates a somewhat cheap valuation: SCANA is cheaper than 76.64% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.17
EV/EBITDA 7.98
SCANA.OL Per share dataSCANA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SCANA's earnings are expected to grow with 34.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.49
PEG (5Y)0.45
EPS Next 2Y39.53%
EPS Next 3Y34.8%

0

5. Dividend

5.1 Amount

No dividends for SCANA!.
Industry RankSector Rank
Dividend Yield N/A

SCANA ASA

OSL:SCANA (7/22/2025, 9:35:57 AM)

1.528

+0 (+0.13%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-27 2025-02-27/bmo
Earnings (Next)N/A N/A
Inst Owners0.18%
Inst Owner ChangeN/A
Ins Owners10.16%
Ins Owner ChangeN/A
Market Cap705.77M
Analysts86.67
Price Target1.94 (26.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.05
Dividend Growth(5Y)-61.68%
DP228.28%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-9.39%
Min Revenue beat(2)-19.55%
Max Revenue beat(2)0.77%
Revenue beat(4)2
Avg Revenue beat(4)-5.2%
Min Revenue beat(4)-19.55%
Max Revenue beat(4)9.63%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-44.12%
PT rev (3m)-44.12%
EPS NQ rev (1m)-175%
EPS NQ rev (3m)-175%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-19.74%
Revenue NQ rev (3m)-19.74%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.55
Fwd PE 4.79
P/S 0.39
P/FCF 10.17
P/OCF 4.75
P/B 1.11
P/tB 2.78
EV/EBITDA 7.98
EPS(TTM)0.16
EY10.47%
EPS(NY)0.32
Fwd EY20.9%
FCF(TTM)0.15
FCFY9.83%
OCF(TTM)0.32
OCFY21.07%
SpS3.89
BVpS1.38
TBVpS0.55
PEG (NY)0.49
PEG (5Y)0.45
Profitability
Industry RankSector Rank
ROA 0.65%
ROE 1.56%
ROCE 4.15%
ROIC 3.15%
ROICexc 3.15%
ROICexgc 5.04%
OM 2.36%
PM (TTM) 0.55%
GM 54.88%
FCFM 3.86%
ROA(3y)2.29%
ROA(5y)7.89%
ROE(3y)5.28%
ROE(5y)21.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-3.16%
ROICexcg growth 5Y183.75%
ROICexc growth 3Y-15.99%
ROICexc growth 5Y161.08%
OM growth 3Y22.03%
OM growth 5Y228.51%
PM growth 3Y-21.04%
PM growth 5Y11%
GM growth 3Y5.71%
GM growth 5Y6.61%
F-Score6
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 7.98
Debt/EBITDA 2.44
Cap/Depr 68.96%
Cap/Sales 4.41%
Interest Coverage 1.18
Cash Conversion 94.47%
Profit Quality 701.01%
Current Ratio 1.03
Quick Ratio 0.78
Altman-Z N/A
F-Score6
WACC8.08%
ROIC/WACC0.39
Cap/Depr(3y)42.24%
Cap/Depr(5y)32.52%
Cap/Sales(3y)2.81%
Cap/Sales(5y)1.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-93.11%
EPS 3Y-9.23%
EPS 5Y21.2%
EPS Q2Q%-162.54%
EPS Next Y19.33%
EPS Next 2Y39.53%
EPS Next 3Y34.8%
EPS Next 5YN/A
Revenue 1Y (TTM)2.94%
Revenue growth 3Y84.93%
Revenue growth 5Y39.74%
Sales Q2Q%-31.93%
Revenue Next Year1.92%
Revenue Next 2Y9.54%
Revenue Next 3Y10.21%
Revenue Next 5YN/A
EBIT growth 1Y-68.07%
EBIT growth 3Y125.68%
EBIT growth 5Y359.05%
EBIT Next Year82.48%
EBIT Next 3Y36.44%
EBIT Next 5YN/A
FCF growth 1Y6.76%
FCF growth 3Y41.29%
FCF growth 5Y3.96%
OCF growth 1Y81.15%
OCF growth 3Y80.15%
OCF growth 5Y20.9%